Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

TriSalus Life Sciences (TLSIW) Current Leases (2022 - 2025)

TriSalus Life Sciences' Current Leases history spans 4 years, with the latest figure at $167000.0 for Q4 2025.

  • For Q4 2025, Current Leases fell 22.69% year-over-year to $167000.0; the TTM value through Dec 2025 reached $167000.0, down 22.69%, while the annual FY2025 figure was $167000.0, 22.69% down from the prior year.
  • Current Leases reached $167000.0 in Q4 2025 per TLSIW's latest filing, up from $129000.0 in the prior quarter.
  • In the past five years, Current Leases ranged from a high of $379000.0 in Q3 2023 to a low of $118000.0 in Q1 2025.
  • Average Current Leases over 4 years is $255000.0, with a median of $266000.0 recorded in 2024.
  • Peak YoY movement for Current Leases: fell 5.14% in 2023, then crashed 67.49% in 2025.
  • A 4-year view of Current Leases shows it stood at $370000.0 in 2022, then decreased by 5.14% to $351000.0 in 2023, then crashed by 38.46% to $216000.0 in 2024, then dropped by 22.69% to $167000.0 in 2025.
  • Per Business Quant, the three most recent readings for TLSIW's Current Leases are $167000.0 (Q4 2025), $129000.0 (Q3 2025), and $123000.0 (Q2 2025).